Rheumatoid arthritis

The Development of Rheumatoid Arthritis–Specific Ambulatory Care–Sensitive Conditions: Results of a Consensus Process

Arthritis Care Res (Hoboken)Published Consensus study

Authors' conclusion

Consensus was achieved for 13 proposed RA-specific ACSCs that could be used to monitor care access and quality for persons living with RA, determine population-level differences, and appropriately allocate resources.

Study context

Population
Clinical and patient panelists rating candidate conditions for rheumatoid arthritis (RA)-specific ambulatory care-sensitive conditions (ACSCs)49 candidate conditions
Participants
22 vs 8
Comparison
Clinical panelists vs Patient panelists
  • Clinical panelistsn = 22
  • Patient panelistsn = 8
Outcome
Consensus on RA-specific ACSCs (preventability and importance of hospitalization)
Methodological detailsmodified Delphi process, systematic literature review, anonymous voting, RAND/UCLA Appropriateness Method, Clinical panelists: two rounds of anonymous voting with asynchronous discussion board between rounds, Patient panelists: same process on conditions without consensus, Interactive webinar before a final combined panel voting round
  • Modified Delphi process
  • Systematic literature review
  • Anonymous voting
  • RAND/UCLA Appropriateness Method
  • Clinical panelists: two rounds of anonymous voting with asynchronous discussion board between rounds
  • Patient panelists: same process on conditions without consensus
  • Interactive webinar before a final combined panel voting round

Recommendations

As reported in the abstract

Proposed RA-specific ACSCs
Conditions identified as proposed RA-specific ACSCs
13

Original publication

The Development of Rheumatoid Arthritis–Specific Ambulatory Care–Sensitive Conditions: Results of a Consensus Process. Arthritis Care Res (Hoboken). Published 10 August 2026. doi:10.1002/acr.80135

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.